Trabajo Académico

• ORCID
• Google académico
• Scopus

Incidencia en los ODS ONU

Intereses de investigación

• Lupus eritematoso sistémico
• Hiperuricemia asintomática
• Autoinmunidad
• Inflamación
• COVID-19

Semblanza

El Doctor Luis Manuel Amezcua Guerra hizo su Licenciatura en Medicina General en la Facultad de Medicina de la Universidad Nacional Autónoma de México (UNAM) dentro del Programa de Alta Exigencia Académica (PAEA) o Núcleos de Calidad Educativa (NUCE). Realizó un Internado médico de pregrado en el Instituto Nacional de Ciencias Médicas y de la Nutrición Salvador Zubirán (INCMNSZ).

Hizo una Especialidad en Medicina Interna en el Hospital Regional 1 de Octubre del Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado (ISSSTE). Jefe de Residentes de Medicina Interna. Subespecialidad en Reumatología en el Instituto Nacional de Cardiología Ignacio Chávez (INCICh). Jefe de Residentes de Reumatología.

Estudió el Doctorado en Ciencias Biológicas y de la Salud en la Universidad Autónoma Metropolitana y recibió la Medalla al Mérito Universitario.

Es Investigador en Ciencias Médicas del departamento de Inmunología del Instituto Nacional de Cardiología Ignacio Chávez (INCICh) y Coordinador de la Unidad de Investigación en Medicina Traslacional UNAM-INCICh. Jefe del departamento de Inmunología del Instituto Nacional de Cardiología Ignacio Chávez (INCICh).

Profesor e Investigador del departamento de Atención de la Salud de la Unidad Xochimilco de la Universidad Autónoma Metropolitana.

Consejero Titular del Consejo Mexicano de Reumatología (CMR). Miembro Nivel II del Sistema Nacional de Investigadores del Consejo Nacional de Ciencia y Tecnología (CONACYT).

Información proporcionada por el personal académico

Intereses de investigación

• Lupus eritematoso sistémico
• Hiperuricemia asintomática
• Autoinmunidad
• Inflamación
• COVID-19

Trabajo Académico

En las páginas siguientes puede consultar el trabajo de investigación:

• Google académico

Ver publicaciones

• Scopus

Ver publicaciones

• ORCID

Ver publicaciones

Algunos ejemplos de publicaciones

Seleccione la referencia bibliografica para consultar cada publicación:

Open Access	Referencias	ODS ONU
	Amezcua-Guerra, L.M., Brianza-Padilla, M., Martínez-García, M. and 1 more (...) (2026).Establishment of High-Altitude Reference Values for the Pan-Immune-Inflammation Value in Healthy Adults Living in Mexico City. Archives of Medical Research,57(1)
OA	Soberanes-García, M.G., Barragán-Huerta, L., Brianza-Padilla, M. and 3 more (...) (2025).Serum levels of metalloproteinases as predictive biomarkers of adverse cardiovascular events in male patients with ST-segment elevation myocardial infarction. Archivos de Cardiologia de Mexico,95(3) 250-254	\| 3 \|
	Guzmán-García, S., Sacoto-Flores, G., Román-Bermeo, J. and 5 more (...) (2025).Risk predictors for adverse COVID-19 outcomes in Latin American patients with autoimmune rheumatic diseases: A multicentre study in Ecuador and Mexico. Revista Colombiana de Reumatologia,32(2) 152-158	\| 3 \|
OA	Morales-Rentería, A., Ruiz-Santos, A., Amezcua-Castillo, L.M. and 5 more (...) (2025).MIR-155 as a potential biomarker for disease severity in st-segment elevation myocardial infarction: insights from a university-affiliated cardiovascular center. Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion,77(1) 013-025	\| 3 \|
	Miranda-Mendoza, H., Paulino-González, D., Sesma-Soto, J. and 9 more (...) (2025).Establishing reference values for serum urate in healthy adults from Mexico City: Data from the Tlalpan 2020 cohort. Reumatologia Clinica,21(8)
	Amezcua-Guerra, B., Amezcua-Castillo, L.M., Guerra-López, J.A. and 3 more (...) (2025).Cytokine-Based Validation of the Inflammation-Based Risk Score in Patients with ST-Segment Elevation Myocardial Infarction. Journal of Interferon and Cytokine Research,45(3) 91-98
	Amezcua-Guerra, L.M., Roldán-Ortega, J., Mora-Ramírez, M. (2025).Rhupus syndrome: current knowledge and future perspectives. Expert Review of Clinical Immunology,21(12) 1709-1724
OA	Espinosa-Bautista, F., Ramos-Rosillo, V., Vazquez-Panchos, Y. and 6 more (...) (2025).Influence of menopause status on T-helper cell profiles in acute myocardial infarction. Biomolecules and Biomedicine,25(11) 2513-2518
OA	Espinosa-Bautista, F., Ramos-Rosillo, V., Vazquez-Panchos, Y. and 4 more (...) (2025).Insights into the clinical and immunological significance of anti-α-fodrin antibodies in systemic lupus erythematosus. Rheumatology and Immunology Research,6(1) 59-62
OA	Amezcua-Castillo, E., Amezcua-Castillo, L.M., Barragán-Huerta, L. and 2 more (...) (2025).Creatine supplementation as a dual therapeutic strategy for sarcopenia and immune dysregulation in systemic lupus erythematosus: A hypothesis-driven approach. Medical Hypotheses,201
OA	Martínez-Nava, G.A., Altamirano-Molina, E., Vázquez-Mellado, J. and 24 more (...) (2025).Metatranscriptomic analysis reveals gut microbiome bacterial genes in pyruvate and amino acid metabolism associated with hyperuricemia and gout in humans. Scientific Reports,15(1)
OA	Peña-Peña, M., Bermúdez-Benítez, E., Sánchez-Gloria, J.L. and 12 more (...) (2025).A 14-Day Plant-Based Dietary Intervention Modulates the Plasma Levels of Rheumatoid Arthritis-Associated MicroRNAs: A Bioinformatics-Guided Pilot Study. Nutrients ,17(13)
OA	Guzmán-Martín, C.A., Jiménez-Ortega, R.F., Ortega-Springall, M.F. and 6 more (...) (2025).miR-16-5p, miR-21-5p, and miR-155-5p in circulating vesicles as psoriasis biomarkers. Scientific Reports,15(1)
	Espinosa-Bautista, F., Salazar-Sánchez, M.I., Brianza-Padilla, M. and 5 more (...) (2024).Dysregulation of long non-coding RNAs in Takayasu arteritis: A proof-of-concept study. Clinical Rheumatology,43(3) 1253-1259
OA	Cruz-Gregorio, A., Amezcua-Guerra, L.M., Fisher-Bautista, B. and 2 more (...) (2024).The Protective Role of Interleukin-37 in Cardiovascular Diseases through Ferroptosis Modulation. International Journal of Molecular Sciences,25(18)	\| 3 \|
OA	Sáenz-San Martín, A., Méndez-Ocampo, P., Gutiérrez-Moctezuma, I. and 1 more (...) (2024).C-reactive protein, cardiovascular issues of an acute-phase protein: an update for the clinician. Archivos de Cardiologia de Mexico,94(2) 191-202	\| 3 \|
OA	Amezcua-Guerra, L.M., Pazarán-Romero, G., Gutiérrez-Esparza, G.O. and 4 more (...) (2024).Gender assessment of sleep disorders in an adult urban population of Mexico City. Salud Publica de Mexico,66(6) 824-830	\| 10 \|
	Bocanegra-Zamora, F., Espinosa-Bautista, F., Jiménez-Rodríguez, G.M. and 6 more (...) (2024).Senescent CD4+ T-Cell Phenotypes and Inflammatory Milieu in the Coronary and Systemic Circulation in ST-Elevation Myocardial Infarction: An Exploratory Study. Journal of Vascular Research,61(5) 260-266
	Castillo-Martínez, D., Mora-Ramírez, M., Molina-Sánchez, R. and 1 more (...) (2024).The 2023 ACR/EULAR antiphospholipid syndrome classification criteria identify patients at high risk of complications. Clinical Rheumatology,43(11) 3373-3377
OA	Amezcua-Guerra, L.M., Velázquez-Espinosa, K.P., Piña-Soto, L.A. and 3 more (...) (2024).The Self-Reported Quality of Sleep and Its Relationship with the Development of Arterial Hypertension: Perspectives from the Tlalpan 2020 Cohort. Journal of Clinical Medicine,13(20)
OA	Amezcua-Guerra, B., Amezcua-Castillo, L.M., Guerra-López, J.A. and 17 more (...) (2023).Diagnostic Performance of Serum MicroRNAs for ST-Segment Elevation Myocardial Infarction in the Emergency Department. Biomedicines,11(9)	\| 3 \|
OA	Bojalil, R., Ruíz-Hernández, A., Villanueva-Arias, A. and 9 more (...) (2023).Two murine models of sepsis: immunopathological differences between the sexes—possible role of TGFβ1 in female resistance to endotoxemia. Biological Research,56(1)
	Hernández-Solano, L., Amezcua-Castillo, E., Amezcua-Guerra, L.M. (2023).Dyslipidemia is not associated with interferon-regulated chemokines or disease activity in systemic lupus erythematosus. Clinical Rheumatology,42(7) 1993-1995
	Guzmán-Martín, C.A., Juárez-Vicuña, Y., Domínguez-López, A. and 4 more (...) (2023).lncRNAs dysregulation in monocytes from primary antiphospholipid syndrome patients: a bioinformatic and an experimental proof-of-concept approach. Molecular Biology Reports,50(1) 937-941
	Amezcua-Guerra, L.M., Carbonell-Bobadilla, N., Soto-Fajardo, C. and 8 more (...) (2023).Influence of anti-carbamylated protein antibodies on disease activity and joint erosions in seronegative and seropositive rheumatoid arthritis. Rheumatology International,43(12) 2245-2250
	Amezcua-Guerra, L.M., Espinosa-Bautista, F., Hopf-Estandía, K. and 12 more (...) (2023).Senescent CD4+CD28null cells are increased in chronic hyperuricemia, show aberrant effector phenotypes, and are reversed after allopurinol therapy: a proof-of-concept pilot study. Clinical Rheumatology,42(8) 2181-2186
OA	Amezcua-Guerra, L.M., Sánchez-Muñoz, F., Guzmán-García, S. and 4 more (...) (2023).Mononuclear cells from patients with rhupus are influenced by TNF in their production of gp130/sIL-6Rb and APRIL. Lupus Science and Medicine,10(2)	\| 3 \|
OA	Díaz-Domínguez, K.A., Cruz-Melendez, A., Amezcua-Castillo, L.M. and 4 more (...) (2023).Should a recent SARS-CoV-2 infection be considered a risk or prognostic factor for ST-segment elevation myocardial infarction?. Archivos de Cardiologia de Mexico,9316-21	\| 3 \|
OA	Amezcua-Guerra, L.M., Guzmán-Martín, C.A., Montúfar-Robles, I. and 5 more (...) (2023).CD147 rs8259T>A Variant Confers Susceptibility to COVID-19 Infection within the Mexican Population. Microorganisms,11(8)	\| 3 \|
OA	Amezcua-Castillo, E., González-Pacheco, H., Sáenz-San Martín, A. and 8 more (...) (2023).C-Reactive Protein: The Quintessential Marker of Systemic Inflammation in Coronary Artery Disease—Advancing toward Precision Medicine. Biomedicines,11(9)	\| 3 \|
	Springall, R., Ortega-Springall, M.F., Guerrero-Ponce, A.E. and 2 more (...) (2023).Interleukin-17 and Tumor Necrosis Factor Show a Functional Hierarchy to Regulate the Production of Matrix Metalloproteases by Monocytes from Patients with Psoriasis. Journal of Interferon and Cytokine Research,43(3) 140-146	\| 3 \|
	Brianza-Padilla, M., Juárez-Vicuña, Y., Springall, R. and 3 more (...) (2022).Antinuclear antibodies detected by Enzyme-Linked Immunosorbent Assay (ELISA) in severe COVID-19: Clinical and laboratory associations. European Review for Medical and Pharmacological Sciences,26(14) 5307-5310	\| 3 \|
	Guerra-López, J.A., Amezcua-Castillo, L.M., González-Pacheco, H. and 1 more (...) (2022).Levels of Vascular Endothelial Growth Factor and Its Association with Pulmonary Embolism in COVID-19. Journal of Interferon and Cytokine Research,42(8) 444-448	\| 3 \|
OA	Springall, R., González-Flores, J., García-Ávila, C. and 14 more (...) (2022).Elevated Levels of Soluble CD147 are Associated with Hyperinflammation and Disease Severity in COVID-19: A Proof-of-Concept Clinical Study. Archivum Immunologiae et Therapiae Experimentalis,70(1)	\| 3 \|
OA	Carbonell-Bobadilla, N., Soto-Fajardo, C., Amezcua-Guerra, L.M. and 7 more (...) (2022).Patients with seronegative rheumatoid arthritis have a different phenotype than seropositive patients: A clinical and ultrasound study. Frontiers in Medicine,9	\| 3 \|
	Espinosa-Bautista, F., Coronel, D., Ramos-Rosillo, V. and 1 more (...) (2022).Performance analysis of Luminex and ELISA to profile serum IP-10 as a biomarker in systemic lupus erythematosus. Lupus,31(13) 1660-1665
OA	Amezcua-Guerra, L.M., Sánchez-Muñoz, F., Pichardo-Ontiveros, E. and 3 more (...) (2022).Interferon-alpha regulates expression of lncRNA MALAT1 and interferon-stimulated genes, as well as chemokine production, in primary Sjögren’s syndrome. Clinical and Experimental Rheumatology,40(12) 2275-2282
OA	Amezcua-Guerra, L.M., Mora-Ramirez, M., Vancini, G. and 2 more (...) (2022).Fibroblast Growth Factor 23 Levels in Pulmonary Involvement Associated With Systemic Sclerosis: A Proof-of-concept Study. Journal of Rheumatology,49(5) 542-544
OA	Hernández-Díazcouder, A., González-Ramírez, J., Sanchez, F. and 4 more (...) (2022).Negative Effects of Chronic High Intake of Fructose on Lung Diseases. Nutrients,14(19)	\| 3 \|
	Juárez-Vicuña, Y., Guzmán-Martín, C.A., Martínez-Martínez, L.A. and 7 more (...) (2021).miR-19b-3p and miR-20a-5p are associated with the levels of antiphospholipid antibodies in patients with antiphospholipid syndrome. Rheumatology International,41(7) 1329-1335
OA	Castillo-Martínez, D., Torres, Z., Amezcua-Guerra, L.M. and 1 more (...) (2021).Are antiphospholipid antibodies just a common epiphenomenon or are they causative of immune-mediated coagulopathy in COVID-19?. Clinical Rheumatology,40(7) 3015-3019	\| 3 \|
OA	González-Flores, J., García-ávila, C., Springall, R. and 16 more (...) (2021).Usefulness of easy-to-use risk scoring systems rated in the emergency department to predict major adverse outcomes in hospitalized covid-19 patients. Journal of Clinical Medicine,10(16)	\| 3 \|
OA	Amezcua-Guerra, L.M., Audelo, K., Guzmán, J. and 8 more (...) (2021).A simple and readily available inflammation-based risk scoring system on admission predicts the need for mechanical ventilation in patients with COVID-19. Inflammation Research,70(6) 731-742	\| 3 \|
	Patlán, M., Páez, A., Massó, F. and 1 more (...) (2021).Relative increase of Th17 phenotype in senescent CD4+CD28null T cells from peripheral blood of patients with rheumatoid arthritis. Clinical and Experimental Rheumatology,39(4) 925-926
	Mora-Ramírez, M., Amezcua-Guerra, L.M. (2021).The role of type III interferons in systemic autoimmune diseases. Translational Autoimmunity: Etiology of Autoimmune Diseases,199-212
OA	Juárez-Vicuña, Y., Pérez-Ramos, J., Adalid-Peralta, L. and 8 more (...) (2021).Interferon Lambda 3/4 (IFNλ3/4) rs12979860 Polymorphisms Is Not Associated With Susceptibility to Systemic Lupus Erythematosus, Although It Regulates OASL Expression in Patients With SLE. Frontiers in Genetics,12
	Castillo-Martínez, D., Amezcua-Castillo, L.M., Granados, J. and 2 more (...) (2020).Is Takayasu arteritis the result of a Mycobacterium tuberculosis infection? The use of TNF inhibitors may be the proof-of-concept to demonstrate that this association is epiphenomenal. Clinical Rheumatology,39(6) 2003-2009	\| 3 \|
OA	Marquez-Velasco, R., Vallejo, M., Catrip-Torres, J.M. and 6 more (...) (2020).RESECTION OF THE ATRIAL APPENDAGES AND ITS IMPACT IN THE NATRIURETIC HOMEOSTASIS: DEVELOPMENT AND VALIDATION OF AN ANIMAL MODEL IN AN ACADEMIC MEDICAL CENTER. Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion,72(2) 103-109
	Hernández-Rodríguez, R.T., Amezcua-Guerra, L.M. (2020).The potential role of microRNAs as biomarkers in atopic dermatitis: A systematic review. European Review for Medical and Pharmacological Sciences,24(22) 11804-11809
	Amezcua-Castillo, L.M., Juárez-Vicuña, Y., Márquez-Velasco, R. and 1 more (...) (2020).Activation Status of NLRP3 Inflammasome in Peripheral Blood Mononuclear Cells From Patients With Gout Flare. Journal of Clinical Rheumatology,26S208-S212
	Amezcua-Guerra, L.M., Ortega-Springall, M.F., Guerrero-Ponce, A.E. and 2 more (...) (2020).Interleukin-17A enhances the production of CD147/extracellular matrix metalloproteinase inducer by monocytes from patients with psoriasis. European Review for Medical and Pharmacological Sciences,24(20) 10601-10604
	Juárez-Vicuña, Y., Pérez-Ramos, J., Adalid-Peralta, L. and 9 more (...) (2020).The presence of IFL3/4 rs12979860 C allele influences the in vitro IP-10 production by mononuclear cells from patients with systemic lupus erythematosus. Lupus,29(5) 482-489

Cursos impartidos en los últimos trimestres

No.	Trim.	Nombre UEA	Nivel
1	25O	Atención Integral del Adulto I	Licenciatura
2	25O	Trabajo de Investigación VII	Posgrado
3	25O	Atención Integral del Adulto I	Licenciatura
4	25P	Atención Integral del Adulto I	Licenciatura
5	25P	Seminario VI	Posgrado
6	25P	Trabajo de Investigación VI	Posgrado
7	25I	Atención Integral del Adulto I	Licenciatura
8	25I	Seminario V	Posgrado
9	25I	Trabajo de Investigación V	Posgrado
10	24O	Atención Integral del Adulto I	Licenciatura
11	24O	Seminario IV	Posgrado
12	24O	Trabajo de Investigación IV	Posgrado
13	24P	Seminario III	Posgrado
14	24P	Trabajo de Investigación III	Posgrado
15	24P	Atención Integral del Adulto I	Licenciatura
16	24I	Atención Integral del Adulto I	Licenciatura
17	24I	Seminario II	Posgrado
18	24I	Trabajo de Investigación II	Posgrado
19	23O	Atención Integral del Adulto I	Licenciatura
20	23O	Seminario I	Posgrado
21	23O	Trabajo de Investigación I	Posgrado
22	23P	Atención Integral del Adulto I	Licenciatura
23	23I	Atención Integral del Adulto I	Licenciatura
24	22O	Atención Integral del Adulto I	Licenciatura
25	22P	Atención Integral del Adulto I	Licenciatura
26	22I	Atención Integral del Adulto I	Licenciatura

Información proporcionada por la Dirección de Sistemas Escolares

Regresar al listado